2.78
1.42%
-0.04
HeartBeam Inc stock is currently priced at $2.78, with a 24-hour trading volume of 98,463.
It has seen a -1.42% decreased in the last 24 hours and a +38.31% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.87 pivot point. If it approaches the $2.75 support level, significant changes may occur.
Previous Close:
$2.82
Open:
$2.84
24h Volume:
98,463
Market Cap:
$73.19M
Revenue:
-
Net Income/Loss:
$-14.47M
P/E Ratio:
-1.7935
EPS:
-1.55
Net Cash Flow:
$-12.19M
1W Performance:
+2.21%
1M Performance:
+38.31%
6M Performance:
+91.72%
1Y Performance:
+18.30%
HeartBeam Inc Stock (BEAT) Company Profile
Name
HeartBeam Inc
Sector
Industry
Phone
408 899 4443
Address
2118 Walsh Avenue, Suite 210, Santa Clara
HeartBeam Inc Stock (BEAT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-11-20 | Initiated | Needham | Buy |
Sep-02-20 | Initiated | Robert W. Baird | Neutral |
Jan-08-20 | Initiated | SunTrust | Buy |
Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Apr-26-19 | Reiterated | Dougherty & Company | Buy |
Jul-26-18 | Reiterated | Lake Street | Buy |
Apr-26-18 | Reiterated | The Benchmark Company | Buy |
Feb-23-18 | Reiterated | Dougherty & Company | Buy |
Nov-08-17 | Reiterated | Dougherty & Company | Buy |
Oct-26-17 | Initiated | Raymond James | Outperform |
Oct-24-17 | Initiated | SunTrust | Buy |
Aug-09-17 | Reiterated | Dougherty & Company | Buy |
Jul-19-17 | Reiterated | The Benchmark Company | Buy |
Apr-11-17 | Reiterated | Dougherty & Company | Buy |
Dec-02-16 | Initiated | Dougherty & Company | Buy |
Sep-13-16 | Initiated | Sidoti | Buy |
Aug-03-16 | Reiterated | The Benchmark Company | Buy |
Jul-28-15 | Reiterated | Dougherty & Company | Buy |
Oct-24-13 | Initiated | The Benchmark Company | Buy |
Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
HeartBeam Inc Stock (BEAT) Latest News
Examining the Potential Price Growth of HeartBeam Inc (BEAT) – Knox Daily - Knox Daily
Knox Daily
HeartBeam Insiders May Regret Not Buying More, Market Cap Hits US$62m - Simply Wall St
Simply Wall St
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program - The Globe and Mail
The Globe and Mail
HeartBeam's AI device outperforms experts in detecting atrial flutter - Yahoo Finance
Yahoo Finance
HeartBeam's AI device outperforms experts in detecting atrial flutter - Yahoo Finance
Yahoo Finance
HeartBeam Inc (BEAT) Stock: From Low to High in 52 Weeks - The InvestChronicle
The InvestChronicle
HeartBeam Inc Stock (BEAT) Financials Data
HeartBeam Inc (BEAT) Net Income 2024
BEAT net income (TTM) was -$14.47 million for the quarter ending September 30, 2023, a -27.68% decrease year-over-year.
HeartBeam Inc (BEAT) Cash Flow 2024
BEAT recorded a free cash flow (TTM) of -$12.19 million for the quarter ending September 30, 2023, a -29.21% decrease year-over-year.
HeartBeam Inc (BEAT) Earnings per Share 2024
BEAT earnings per share (TTM) was -$1.24 for the quarter ending September 30, 2023, a +11.87% growth year-over-year.
About HeartBeam Inc
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company develops three-dimensional (3D)-vector electrocardiogram (ECG) platform for heart attack detection. It is developing HeartBeam AIMI software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack; and HeartBeam AIMIGo, a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
Cap:
|
Volume (24h):